capsaicin and fluo-3

capsaicin has been researched along with fluo-3 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brough, SJ; Cairns, W; Davis, JB; Gunthorpe, MJ; Hayes, PD; Jerman, JC; Randall, AD; Ranson, J; Smart, D1
Davies, CH; Davis, JB; Egerton, J; Gill, CH; Gunthorpe, MJ; Howett, L; Jerman, JC; Lappin, SC; Luis Hannan, S; Nasir, S; Owen, D; Rami, HK; Randall, AD; Smart, D; Smith, GD; Soffin, EM; Thompson, M; Worby, A; Wyman, PA1

Other Studies

2 other study(ies) available for capsaicin and fluo-3

ArticleYear
Characterisation using FLIPR of human vanilloid VR1 receptor pharmacology.
    European journal of pharmacology, 2001, Apr-06, Volume: 417, Issue:1-2

    Topics: Alkaloids; Aniline Compounds; Arachidonic Acids; Benzophenanthridines; Calcium; Capsaicin; Cell Line; Diterpenes; Dose-Response Relationship, Drug; Endocannabinoids; Enzyme Inhibitors; Fluorescence; Fluorometry; Humans; Hydrogen-Ion Concentration; Membrane Potentials; Phenanthridines; Polycyclic Sesquiterpenes; Polyunsaturated Alkamides; Protein Kinase C; Receptors, Drug; Ruthenium Red; Sesquiterpenes; Time Factors; Xanthenes

2001
Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonist.
    Neuropharmacology, 2004, Volume: 46, Issue:1

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Acids; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Anilides; Aniline Compounds; Animals; Calcium; Capsaicin; Carrier Proteins; Cell Line; Cinnamates; Dose-Response Relationship, Drug; Drug Interactions; Embryo, Mammalian; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Hot Temperature; Humans; Intracellular Signaling Peptides and Proteins; Kidney; Membrane Potentials; N-Methylaspartate; Neuropeptides; Norepinephrine; Orexins; Patch-Clamp Techniques; Protein Binding; Radioligand Assay; Rats; Receptors, Drug; Serotonin Receptor Agonists; Xanthenes

2004